SCHEMBL31353091

SCHEMBL31353091

O=c1[nH]c2cc(Br)ccc2c2c1CCOC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WNT3A P56704 3/20 0.50
TNKS2 Q9H2K2 3/20 0.50
METAP2 P50579 1/20 0.41
PARP1 P09874 2/20 0.41
PARP2 Q9UGN5 1/20 0.41
CCNB2 O95067 1/20 0.40
CDK1 P06493 1/20 0.40
CCNB1 P14635 1/20 0.40
GSK3B P49841 1/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
CCNB3 Q8WWL7 1/20 0.40
ALDH1A1 P00352 3/20 0.37
HSD17B10 Q99714 2/20 0.37
TSHR P16473 1/20 0.37
CASP7 P55210 1/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
MAPK1 P28482 1/20 0.37
PTGES O14684 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31353075 0.94 WNT3A (0.50) WNT3ATNKS2METAP2PARP1PARP2
SCHEMBL6069754 0.80 MAPT (0.51) TNKS2METAP2PARP1PARP2CCNB2
SCHEMBL6407884 0.80 HSD17B10 (0.51) TNKS2METAP2PARP1PARP2CCNB2
SCHEMBL30273069 0.73 HPGD (0.51) TNKS2PARP1PARP2ALDH1A1HSD17B10
SCHEMBL10153752 0.68 PARP1 (0.56) TNKS2METAP2PARP1CCNB2CDK1
SCHEMBL30273158 0.67 PARP1 (0.51) PARP1PARP2
SCHEMBL29203629 0.67 PARP1 (0.56) PARP1ALDH1A1HSD17B10
SCHEMBL30273133 0.67 PARP1 (0.41) PARP1PARP2
SCHEMBL6554641 0.66 PARP1 (0.53) PARP1PARP2
SCHEMBL1003250 0.66 LMNA (0.78) CCNB2CDK1CCNB1GSK3BCDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119143752-A Aminoquinoline derivative, pharmaceutical composition containing same, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-12-17 CN disclosed